<![CDATA[Ground Game]]>The science on psychedelic therapy is accelerating, and the policy is trying to catch up. The people caught in between are the ones who need affordable, accessible care and can't get it yet. Ground Game, from the Center for Psychedelic Policy, talks to the researchers, clinicians, and advocates working at that intersection, translating the momentum into something legislators, funders, and advocates can act on. The podcast is hosted by Sam Chapman, who led the campaign that created the first regulated psilocybin program in the nation.

]]>cppolicy.orgRiverside.fm (https://riverside.com)Sat, 02 May 2026 10:33:30 GMTThu, 23 Apr 2026 00:25:25 GMT60Center for Psychedelic Policy<p>The science on psychedelic therapy is accelerating, and the policy is trying to catch up. The people caught in between are the ones who need affordable, accessible care and can't get it yet. Ground Game, from the Center for Psychedelic Policy, talks to the researchers, clinicians, and advocates working at that intersection, translating the momentum into something legislators, funders, and advocates can act on. The podcast is hosted by Sam Chapman, who led the campaign that created the first regulated psilocybin program in the nation.</p>episodicCenter for Psychedelic Policysam@cppolicy.orgno<![CDATA[Dr. Adie Rae: Inside Oregon's First Federally Funded Psilocybin Study]]>To launch Ground Game, Sam Chapman speaks with Dr. Adie Rae, co-director of the Open Psychedelic Evaluation Nexus, the team at the center of a historic $3.3 million NIDA grant to track outcomes in Oregon's legal psilocybin program.

The conversation covers what Oregon's program has already revealed about safety and efficacy, why real-world data matters, the economic realities of building psilocybin research infrastructure from the ground up, and what this federal investment signals for the future of psychedelic access nationwide.

]]>275d7340-27cc-4580-8117-7278dae7c851Tue, 28 Apr 2026 21:39:55 GMT<p>To launch Ground Game, Sam Chapman speaks with Dr. Adie Rae, co-director of the Open Psychedelic Evaluation Nexus, the team at the center of a historic $3.3 million NIDA grant to track outcomes in Oregon's legal psilocybin program.</p><p></p><p>The conversation covers what Oregon's program has already revealed about safety and efficacy, why real-world data matters, the economic realities of building psilocybin research infrastructure from the ground up, and what this federal investment signals for the future of psychedelic access nationwide.</p>no01:01:0511Dr. Adie Rae: Inside Oregon's First Federally Funded Psilocybin Studyfull